Skip to content

Xtant Medical Holdings XTNT Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$0-100%
Stryker logo
StrykerSYK
$0-100%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$744M+6.3%
Medtronic logo
MedtronicMDT
$1.75B
CONMED logo
CONMEDCNMD
$180M+8.4%

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's debt issuance proceeds?
Xtant Medical Holdings (XTNT) reported debt issuance proceeds of $1.63M in Q1 2026.
How has Xtant Medical Holdings's debt issuance proceeds changed year-over-year?
Xtant Medical Holdings's debt issuance proceeds decreased by 93.5% year-over-year, from $25.16M to $1.63M.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.